Education
About Us
Working with TipRanks
Follow Us
Orasure (DE:EP3)
:EP3
Earnings Data
Report Date
Mar 03, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.16Last Year’s EPS
-0.12Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted OraSure's strategic initiatives, such as the acquisition of BioMedomics and the renewal of important public health programs. However, the call also addressed significant revenue declines in both U.S. and International Diagnostics segments and continued financial losses, indicating a challenging year ahead.Company Guidance
Strategic Transformation and Growth Plans
OraSure continues to advance its strategic transformation, focusing on product diversification and investments in R&D, acquisitions, and partnerships. The company is positioning itself for growth in 2026.
BioMedomics Acquisition
OraSure signed a definitive agreement to acquire BioMedomics, expanding its Diagnostic portfolio with Sickle SCAN, a rapid test for sickle cell disease. This acquisition is expected to leverage existing international sales channels.
Renewal of Together Take Me Home Program
The HIV self-test program, funded by the federal government, was renewed with bipartisan support, ensuring continued revenue and support for OraSure's public health initiatives.
Positive Feedback on HEMAcollect PROTEIN
Since its launch, HEMAcollect PROTEIN has received positive feedback from customers, supporting momentum in the proteomics market for 2026.
Strong Financial Position
OraSure ended Q3 with $216 million in cash and cash equivalents and zero debt, supporting its strategy of investing in growth opportunities.
DE:EP3 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:EP3 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | €2.22 | €2.22 | 0.00% |
Aug 05, 2025 | €2.68 | €2.56 | -4.48% |
May 07, 2025 | €2.46 | €2.38 | -3.25% |
Feb 25, 2025 | €3.78 | €3.56 | -5.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Orasure (DE:EP3) report earnings?
Orasure (DE:EP3) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
What is Orasure (DE:EP3) earnings time?
Orasure (DE:EP3) earnings time is at Mar 03, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Orasure stock?
The P/E ratio of Orasure Technologies is N/A.
What is DE:EP3 EPS forecast?
DE:EP3 EPS forecast for the fiscal quarter 2025 (Q4) is -0.16.